Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Alloy Women’s Health is making menopausal care accessible

From TechCrunch

By Unknown

November 26, 2024

Alloy Women’s Health is making menopausal care accessible

Alloy Women’s Health is making menopausal care accessible

This week on found, Dom and Becca are talking with the co-founders of Alloy Women’s Health. The startup just closed a new funding round to expand its mission of fixing menopause care. Alloy founders, Monica Molenaar and Anne Fulenwider, discussed raising capital in a competitive health tech landscape, their choice to bypass traditional insurance models, and how this funding will help them scale their telehealth platform nationally.

They also discuss:

  • How their co-CEO model was a natural fit for their leadership styles
  • How their platform addresses the supply and demand issue of specialized health care
  • Educating users despite systemic issues such as outdated studies and lack of training in medical schools

Found posts every Tuesday. Subscribe on Apple, Spotify, or wherever you listen to podcasts to be alerted when new episodes drop.

View original article on techcrunch.com

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Prickly Pear Health will showcase how it’s helping women’s brain health at TechCrunch Disrupt 2025

Prickly Pear Health will showcase how it’s helping women’s brain health at TechCrunch Disrupt 2025

Prickly Pear Health provides medical support for women’s brain health, a voice-first, AI-powered companion that helps women in their 30s to 50s navigate the hormonal changes that affect brain health.

Oct 1, 2025

A new $25M fund aims to give UK mental health startups a shot in the arm

A new $25M fund aims to give UK mental health startups a shot in the arm

In case you hadn’t noticed, there are a lot of mental health startups out there these days, many of which were prompted to launch following the pandemic and the subsequent widespread focus on mental health. However, they often have scant relationships with clinical trials or healthcare systems. A new venture from the U.K.’s KHP Ventures, is planning to correct that by raising a new £20 million ($25.5 million) fund specifically aimed at accelerating startups that are addressing depression, anxi

Dec 12, 2024

European unicorn Alan becomes Canada’s first new health insurance company in almost 70 years

European unicorn Alan becomes Canada’s first new health insurance company in almost 70 years

In 2016, when Alan originally launched its health insurance product in France, it was the first new health insurance company in the country in 30 years. Now, as Alan announces its expansion to Canada, the startup is about to break a new record: There hasn’t been a new health insurance company in Canada since 1957. In many ways, Alan treats health insurance as software as a service. It’s a subscription-first product that can be optimized with technology. For instance, Alan has built its own clai

Oct 9, 2024

Esther and Anne Wojcicki back new healthcare accelerator, fund

Esther and Anne Wojcicki back new healthcare accelerator, fund

Mary Minno launches early-stage startup accelerator program, Treehub, and an early-stage firm, AI Health Fund, aimed at backing startups working at the intersection of healthcare and AI.

Apr 22, 2026

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Prickly Pear Health will showcase how it’s helping women’s brain health at TechCrunch Disrupt 2025

Prickly Pear Health will showcase how it’s helping women’s brain health at TechCrunch Disrupt 2025

Prickly Pear Health provides medical support for women’s brain health, a voice-first, AI-powered companion that helps women in their 30s to 50s navigate the hormonal changes that affect brain health.

Oct 1, 2025

A new $25M fund aims to give UK mental health startups a shot in the arm

A new $25M fund aims to give UK mental health startups a shot in the arm

In case you hadn’t noticed, there are a lot of mental health startups out there these days, many of which were prompted to launch following the pandemic and the subsequent widespread focus on mental health. However, they often have scant relationships with clinical trials or healthcare systems. A new venture from the U.K.’s KHP Ventures, is planning to correct that by raising a new £20 million ($25.5 million) fund specifically aimed at accelerating startups that are addressing depression, anxi

Dec 12, 2024

European unicorn Alan becomes Canada’s first new health insurance company in almost 70 years

European unicorn Alan becomes Canada’s first new health insurance company in almost 70 years

In 2016, when Alan originally launched its health insurance product in France, it was the first new health insurance company in the country in 30 years. Now, as Alan announces its expansion to Canada, the startup is about to break a new record: There hasn’t been a new health insurance company in Canada since 1957. In many ways, Alan treats health insurance as software as a service. It’s a subscription-first product that can be optimized with technology. For instance, Alan has built its own clai

Oct 9, 2024

Esther and Anne Wojcicki back new healthcare accelerator, fund

Esther and Anne Wojcicki back new healthcare accelerator, fund

Mary Minno launches early-stage startup accelerator program, Treehub, and an early-stage firm, AI Health Fund, aimed at backing startups working at the intersection of healthcare and AI.

Apr 22, 2026